{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-21-032360","form_type":"8-K","ticker":"CODX","cik":"0001692415","company_name":"Co-Diagnostics, Inc.","filed_at":"2021-12-23T23:59:59+00:00","discovered_at":"2026-05-14T18:04:13.708673+00:00","generated_at":"2026-06-27T22:37:11.087837+00:00","sec_items":["1.01","3.02","7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Co-Diagnostics acquires Idaho Molecular and Advanced Conceptions for up to 4.72M shares and warrants","bullets":["Total consideration: up to 4.72M shares of CODX common stock and 465,000 warrants at $9.125 exercise price.","Acquisition provides all existing and future assets and IP for at-home/point-of-care PCR device (Eikon/YourTest).","Closings expected by December 31, 2021; each target becomes wholly owned subsidiary of CODX.","Dr. Kirk Ririe to become president of subsidiary; Dr. Carl Wittwer named Chairman of Scientific Advisory Board.","CODX commits to fund development; deal streamlines commercialization and avoids future royalties."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-21-032360","json":"https://secwatch.observer/filing/0001493152-21-032360.json","markdown":"https://secwatch.observer/filing/0001493152-21-032360.md","text":"https://secwatch.observer/filing/0001493152-21-032360.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1692415/000149315221032360/0001493152-21-032360-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1692415/000149315221032360/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T22:37:11.087837+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}